Daiichi Sankyo, Ranbaxy sales and marketing update

The companies said they launched a hybrid business in Brazil under which Daiichi's Daiichi Sankyo Brasil Farmaceutica Ltda. Brazilian subsidiary will market Ranbaxy's branded antiepileptic generics Bipogine lamotrigine and Selzic oxcarbazepine in Brazil along with providing innovative products. Ranbaxy's Ranbaxy Farmaceutica Ltda. Brazilian subsidiary will continue to independently promote Ranbaxy's other generic products in Brazil and will also enter into branded generics in the country. ...